206 related articles for article (PubMed ID: 28414889)
1. Proteomics in pediatric cystic craniopharyngioma.
Massimi L; Martelli C; Caldarelli M; Castagnola M; Desiderio C
Brain Pathol; 2017 May; 27(3):370-376. PubMed ID: 28414889
[TBL] [Abstract][Full Text] [Related]
2. Proteomic characterization of pediatric craniopharyngioma intracystic fluid by LC-MS top-down/bottom-up integrated approaches.
Martelli C; Iavarone F; Vincenzoni F; Rossetti DV; D'Angelo L; Tamburrini G; Caldarelli M; Di Rocco C; Messana I; Castagnola M; Desiderio C
Electrophoresis; 2014 Aug; 35(15):2172-83. PubMed ID: 24729313
[TBL] [Abstract][Full Text] [Related]
3. Identification of thymosins β4 and β 10 in paediatric craniopharyngioma cystic fluid.
Desiderio C; Martelli C; Rossetti DV; Di Rocco C; D'Angelo L; Caldarelli M; Tamburrini G; Iavarone F; Castagnola M; Messana I; Cabras T; Faa G
Childs Nerv Syst; 2013 Jun; 29(6):951-60. PubMed ID: 23503632
[TBL] [Abstract][Full Text] [Related]
4. Adamantinomatous craniopharyngioma: advances in proteomic research.
Desiderio C; Rossetti DV; Castagnola M; Massimi L; Tamburrini G
Childs Nerv Syst; 2021 Mar; 37(3):789-797. PubMed ID: 32617710
[TBL] [Abstract][Full Text] [Related]
5. Molecular Analyses Reveal Inflammatory Mediators in the Solid Component and Cyst Fluid of Human Adamantinomatous Craniopharyngioma.
Donson AM; Apps J; Griesinger AM; Amani V; Witt DA; Anderson RCE; Niazi TN; Grant G; Souweidane M; Johnston JM; Jackson EM; Kleinschmidt-DeMasters BK; Handler MH; Tan AC; Gore L; Virasami A; Gonzalez-Meljem JM; Jacques TS; Martinez-Barbera JP; Foreman NK; Hankinson TC;
J Neuropathol Exp Neurol; 2017 Sep; 76(9):779-788. PubMed ID: 28859336
[TBL] [Abstract][Full Text] [Related]
6. The role of inflammation in the genesis of the cystic component of craniopharyngiomas.
Pettorini BL; Inzitari R; Massimi L; Tamburrini G; Caldarelli M; Fanali C; Cabras T; Messana I; Castagnola M; Di Rocco C
Childs Nerv Syst; 2010 Dec; 26(12):1779-84. PubMed ID: 20668862
[TBL] [Abstract][Full Text] [Related]
7. Adamantinomatous craniopharyngioma cyst fluid can trigger inflammatory activation of microglia to damage the hypothalamic neurons by inducing the production of β-amyloid.
Ainiwan Y; Chen Y; Mao C; Peng J; Chen S; Wei S; Qi S; Pan J
J Neuroinflammation; 2022 May; 19(1):108. PubMed ID: 35525962
[TBL] [Abstract][Full Text] [Related]
8. Investigating the Protein Signature of Adamantinomatous Craniopharyngioma Pediatric Brain Tumor Tissue: Towards the Comprehension of Its Aggressive Behavior.
Martelli C; Serra R; Inserra I; Rossetti DV; Iavarone F; Vincenzoni F; Castagnola M; Urbani A; Tamburrini G; Caldarelli M; Massimi L; Desiderio C
Dis Markers; 2019; 2019():3609789. PubMed ID: 31191748
[TBL] [Abstract][Full Text] [Related]
9. Interleukin‑6 induces an epithelial‑mesenchymal transition phenotype in human adamantinomatous craniopharyngioma cells and promotes tumor cell migration.
Zhou J; Zhang C; Pan J; Chen L; Qi ST
Mol Med Rep; 2017 Jun; 15(6):4123-4131. PubMed ID: 28487953
[TBL] [Abstract][Full Text] [Related]
10. Adamantinomatous craniopharyngioma: moving toward targeted therapies.
Hengartner AC; Prince E; Vijmasi T; Hankinson TC
Neurosurg Focus; 2020 Jan; 48(1):E7. PubMed ID: 31896087
[TBL] [Abstract][Full Text] [Related]
11. Proteomic study of pilocytic astrocytoma pediatric brain tumor intracystic fluid.
Inserra I; Iavarone F; Martelli C; D'Angelo L; Delfino D; Rossetti DV; Tamburrini G; Massimi L; Caldarelli M; Di Rocco C; Messana I; Castagnola M; Desiderio C
J Proteome Res; 2014 Nov; 13(11):4594-606. PubMed ID: 25254300
[TBL] [Abstract][Full Text] [Related]
12. Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target.
Apps JR; Carreno G; Gonzalez-Meljem JM; Haston S; Guiho R; Cooper JE; Manshaei S; Jani N; Hölsken A; Pettorini B; Beynon RJ; Simpson DM; Fraser HC; Hong Y; Hallang S; Stone TJ; Virasami A; Donson AM; Jones D; Aquilina K; Spoudeas H; Joshi AR; Grundy R; Storer LCD; Korbonits M; Hilton DA; Tossell K; Thavaraj S; Ungless MA; Gil J; Buslei R; Hankinson T; Hargrave D; Goding C; Andoniadou CL; Brogan P; Jacques TS; Williams HJ; Martinez-Barbera JP
Acta Neuropathol; 2018 May; 135(5):757-777. PubMed ID: 29541918
[TBL] [Abstract][Full Text] [Related]
13. Drug priming enhances radiosensitivity of adamantinomatous craniopharyngioma via downregulation of survivin.
Stache C; Bils C; Fahlbusch R; Flitsch J; Buchfelder M; Stefanits H; Czech T; Gaipl U; Frey B; Buslei R; Hölsken A
Neurosurg Focus; 2016 Dec; 41(6):E14. PubMed ID: 27903123
[TBL] [Abstract][Full Text] [Related]
14. Intracystic interferon-alpha in pediatric craniopharyngioma patients: an international multicenter assessment on behalf of SIOPE and ISPN.
Kilday JP; Caldarelli M; Massimi L; Chen RH; Lee YY; Liang ML; Parkes J; Naiker T; van Veelen ML; Michiels E; Mallucci C; Pettorini B; Meijer L; Dorfer C; Czech T; Diezi M; Schouten-van Meeteren AYN; Holm S; Gustavsson B; Benesch M; Müller HL; Hoffmann A; Rutkowski S; Flitsch J; Escherich G; Grotzer M; Spoudeas HA; Azquikina K; Capra M; Jiménez-Guerra R; MacDonald P; Johnston DL; Dvir R; Constantini S; Kuo MF; Yang SH; Bartels U
Neuro Oncol; 2017 Oct; 19(10):1398-1407. PubMed ID: 28499018
[TBL] [Abstract][Full Text] [Related]
15. Differential Expression of Stem Cell Markers in Human Adamantinomatous Craniopharyngioma and Pituitary Adenoma.
Chang CV; Araujo RV; Cirqueira CS; Cani CM; Matushita H; Cescato VA; Fragoso MC; Bronstein MD; Zerbini MC; Mendonca BB; Carvalho LR
Neuroendocrinology; 2017; 104(2):183-193. PubMed ID: 27161333
[TBL] [Abstract][Full Text] [Related]
16. High expression levels of CXCL12 and CXCR4 predict recurrence of adamanti-nomatous craniopharyngiomas in children.
Gong J; Zhang H; Xing S; Li C; Ma Z; Jia G; Hu W
Cancer Biomark; 2014; 14(4):241-51. PubMed ID: 24934367
[TBL] [Abstract][Full Text] [Related]
17. Prediction of CTNNB1 Mutation Status in Pediatric Cystic Adamantinomatous Craniopharyngioma by Using Preoperative Magnetic Resonance Imaging Manifestation.
Zhu W; Tang T; Yuan S; Chang B; Li S; Chen M
Clin Neurol Neurosurg; 2021 Jan; 200():106347. PubMed ID: 33160718
[TBL] [Abstract][Full Text] [Related]
18. Unraveling the complexity of the senescence-associated secretory phenotype in adamantinomatous craniopharyngioma using multimodal machine learning analysis.
Prince EW; Apps JR; Jeang J; Chee K; Medlin S; Jackson EM; Dudley R; Limbrick D; Naftel R; Johnston J; Feldstein N; Prolo LM; Ginn K; Niazi T; Smith A; Kilburn L; Chern J; Leonard J; Lam S; Hersh DS; Gonzalez-Meljem JM; Amani V; Donson AM; Mitra SS; Bandopadhayay P; Martinez-Barbera JP; Hankinson TC
Neuro Oncol; 2024 Jun; 26(6):1109-1123. PubMed ID: 38334125
[TBL] [Abstract][Full Text] [Related]
19. Multiplexed immunofluorescence reveals potential PD-1/PD-L1 pathway vulnerabilities in craniopharyngioma.
Coy S; Rashid R; Lin JR; Du Z; Donson AM; Hankinson TC; Foreman NK; Manley PE; Kieran MW; Reardon DA; Sorger PK; Santagata S
Neuro Oncol; 2018 Jul; 20(8):1101-1112. PubMed ID: 29509940
[TBL] [Abstract][Full Text] [Related]
20. In-depth proteomic profiling captures subtype-specific features of craniopharyngiomas.
Kim JH; Kim H; Dan K; Kim SI; Park SH; Han D; Kim YH
Sci Rep; 2021 Oct; 11(1):21206. PubMed ID: 34707096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
